Trial Profile
A Phase II, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of 10 Weeks Treatment with Fluoxetine 20 mg and Computer Software-Based Training in Adult Patients with Amblyopia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2014
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Amblyopia
- Focus Therapeutic Use
- Sponsors Hermo Pharma
- 03 Nov 2014 New trial record